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be cured solely by liver transplantation (Song & Chen,
1992). Therefore while it is obvious that the main
problem(s) reside in the liver, I feel that other genes
may be involved which might be expressed in some
advanced liver diseases. There may be other forms of
Wilson or Pseudo-Wilson disease of which we are not
aware (Kashani, 1977). Even successful treatment of
WD with disappearance of KF ring will not correct
genetic defects of ceruloplasmin deficiency in the body.
The copper metalloenzymes such as amine oxidase,
cytochrome C oxidase, dopamine beta oxidase and
other copper related activities remain defective. Hence
investigation in these areas and their relationship to
ERG activity should be pursued.
Studies by electron microscopy (EM), X-ray energy
spectroscopy (XES), and atomic absorption spec-
trophotometry (AAS) also show that copper is de-
posited next to the endothelium of the cornea and is
associated with a high concentration of sulfur (in form
of metallothioneins) in the area of KF. It appears that
copper is transported by an active process in these cells
(Johnson & Campell, 1982; Van Wassenaer-van Hall,
1997). Other cells with high metabolic activity such as
those in the liver and kidney are also involved (Bull &
Cox, 1994). In addition, a study with single-photon
emission computed tomography (SPECT) indicates
neurological deficits even in treated WD patients
(Oertel, Tatsch, Schwarz, Kraft, Trenkwalder & Scherer
et al., 1992). Therefore, I suggest an ERG study on
Wilson’s Disease patients before and after treatment
and comparison of such data with the author’s findings.
The only report in the literature (up to the best of my
knowledge) which hints to the possible involvement of
retina in copper metabolism is my paper which was
presented in 1977 in England (Kashani, 1977). In my
report of 25 Wilson cases, I noticed that deposition of
copper started in the sequence of superior, inferior,
temporal and nasal side of each cornea with 5 year
observations but did not improve appreciably on D-
penicillinamin with mean follow-up times of one year. I
suggested, for the first time, that copper deposits should
be found on Bruch’s membrane too and this is related
to the activities of the retinal pigment epithelium
(RPE). In my opinion, ultrastructural features and the
copper content of Bruch’s membrane and RPE in
Wilson’s Disease have been neglected and require atten-
tion in future research. The author’s paper may offer a
new approach for research in this complicated area.
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Reply to Dr Kashani
Dear Mr Kashani,
Thank you very much for your interesting comment
on our paper.
You raise the question if there are other causes for
reduced ERG’s in the patients with advanced liver
disease which can cause hepatic encephalopathia. We
directed our attention to ammonia because of its cen-
tral role in the GABA and glutamine:glutamate
metabolism. Other substances may influence it as well,
but to a minor degree (Norenberg, 1996; Butterworth,
1996). The role of copper is very difficult to assess.
In the clinical investigation no patient was found
who displayed a Pseudo-Kayser-Fleischerring. So from
this point of view, there was no hint for severe sec-
ondary copper deposition. The cause of liver cirrhosis
was very heterogeneous in our group, represented
mainly by posthepatic origin of liver damage. Only one
patient suffered from chronic cholestatic liver disease,
.
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known to be associated with severe accumulation of
copper in the tissue. This patient, however, did not
show noticeable differences in comparison to the pa-
tients with the same stage of hepatic encephalopathy as
far as the ERG is concerned.
Measurements of ceruloplasmin and copper were not
performed, because the cause of liver cirrhosis was
ascertained by other means. Methodically the estima-
tion of ceruloplasmin in serum is very problematic, if
conclusions would be drawn to the presence of copper
accumulation. Ceruloplasmin as an acute phase protein
is regulated up by diverse processes. Copper levels
themselves do not correlate with copper accumulation
in the tissue. Local estimations of copper in the eye are
prohibited because of ethical reasons in this experimen-
tal setting.
The next question is, can the copper levels, which
may be increased in patients with chronic liver diseases
cause ERG changes? Hirayama (1990) localized zinc
and copper histochemically in rat ocular tissues. Cop-
per was demonstrated by the rubeanic acid and rhoda-
nine methods. Copper was seen in the corneal
epithelium and endothelium, iris, ciliary body, lens
epithelium, retinal outer nuclear layer, photoreceptor
inner and outer segments, retinal pigment epithelium,
choroid, sclera, and optic nerve. These trace element
seems to play roles as components of some metalloen-
zymes (Hirayama, Dake & Ameniya, 1992) and may
have other functions, still unknown.
Can pathologically high levels cause ERG changes?
ERG changes due to copper are known from ocular
injuries with foreign bodies or from experimental in-
duced metallosis (Schmidt, 1987). Moschos, Panagakis,
Palimeris and Velissaropoulos (1977) studied the elec-
troretinographic alterations and the histological lesions
after the introduction of foreign (iron and copper)
bodies into the vitreous body of eyes of rabbits. The
ERG alterations depend on the kind of intraocular
foreign body and on the size and time it remained in
the eye. Alterations due to copper were characterised
either by a parallel diminution of the a and b wave of
the ERG, or by an increase of the a wave while the b
wave became flat. In histological studies, it was found
that the copper causes a violent inflammatory reaction
and was deposited extracellularly.
Although there are no data, it is safe to assume that
in metallosis, induced by foreign bodies in the eye, toxic
ocular copper levels are much higher than the levels
measured in ocular tissues of patients with liver disease.
Therefore no direct conclusions can be drawn from
investigations with intraocular foreign bodies.
The only sensible way to answer this interesting
question concerning the role of copper metabolism for
retinal function would be either an animal experiment
or the investigation of different stages of hepatic en-
cephalopathy in a homogenous population of patients
with verified copper storage disease.
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